These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10789083)

  • 1. [Follicular dyskeratosis: successful treatment with local retinoid].
    Oster-Schmidt C; Stücker M; Altmeyer P
    Hautarzt; 2000 Mar; 51(3):196-9. PubMed ID: 10789083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tazarotene gel for Darier's disease.
    Burkhart CG; Burkhart CN
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):1001-2. PubMed ID: 9632016
    [No Abstract]   [Full Text] [Related]  

  • 3. Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy.
    Brazzelli V; Prestinari F; Barbagallo T; Vassallo C; Agozzino M; Borroni G
    Eur J Dermatol; 2006; 16(1):59-61. PubMed ID: 16436344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Darier's disease.
    Burge S
    Clin Exp Dermatol; 1999 Mar; 24(2):53-6. PubMed ID: 10233651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tazarotene and acitretin in psoriasis.
    Heath MS; Sahni DR; Curry ZA; Feldman SR
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety of tazarotene in the treatment of plaque psoriasis.
    Marks R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tazarotene foam, 0.1%, for the treatment of acne.
    Smith JA; Narahari S; Hill D; Feldman SR
    Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Guenther LC; Poulin YP; Pariser DM
    Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tazarotene is an effective therapy for elastosis perforans serpiginosa.
    Outland JD; Brown TS; Callen JP
    Arch Dermatol; 2002 Feb; 138(2):169-71. PubMed ID: 11843635
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
    Tang-Liu DD; Matsumoto RM; Usansky JI
    Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene gel in childhood Darier disease.
    Micali G; Nasca MR
    Pediatr Dermatol; 1999; 16(3):243-4. PubMed ID: 10383788
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of topical tazarotene in the treatment of congenital ichthyoses.
    Hofmann B; Stege H; Ruzicka T; Lehmann P
    Br J Dermatol; 1999 Oct; 141(4):642-6. PubMed ID: 10583110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous-hemorrhagic Darier disease.
    Sánchez-Salas MP; Latasa de Aranibar FJ; Oncíns Torres R; Gambó Grasa P
    Skinmed; 2011; 9(1):65-6. PubMed ID: 21409967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
    Leyden J; Lowe N; Kakita L; Draelos Z
    Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
    Rigopoulos D; Gregoriou S; Katsambas A
    Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
    [No Abstract]   [Full Text] [Related]  

  • 19. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
    Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
    Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
    J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.